HIV-1 drug resistance before initiation or re-initiation of first-line antiretroviral therapy in low-income and middle-income countries: a systematic review and meta-regression analysis.
Date
2018
Journal Title
Journal ISSN
Volume Title
Publisher
Elsevier.
Abstract
Abstract available in pdf.
Description
CAPRISA, 2018.
Keywords
Anti-HIV Agents/pharmacology., Developing Countries., HIV Infections/epidemiology., HIV Infections/virology., HIV-1/drug effects., Humans.
Citation
Gupta, R.K., Gregson, J., Parkin, N., Haile-Selassie, H., Tanuri, A., Forero, L.A., Kaleebu, P., Watera, C., Aghokeng, A., Mutenda, N., Dzangare, J., Hone, S., Hang, Z.Z., Garcia, J., Garcia, Z., Marchorro, P., Beteta, E., Giron, A., Hamers, R., Inzaule, S., Frenkel, L.M., Chung, M.H., de Oliveira, T., Pillay, D., Naidoo, K., Kharsany, A., Kugathasan, R., Cutino, T., Hunt, G., Avila Rios, S., Doherty, M., Jordan, M.R. and Bertagnolio, S. 2018. HIV-1 drug resistance before initiation or re-initiation of first-line antiretroviral therapy in low-income and middle-income countries: a systematic review and meta-regression analysis. Lancet Infectious Diseases 18(3), 346-355.